Skip to main content
Premium Trial:

Request an Annual Quote

Robert Saltmarsh, Trevor Nicholls, Tony Colangelo, Olle Landstrm, Michael Treble, Sren Brunak, John Sulston, Anna Tramontano, Martin Vingron, Gunnar von Heijne


Robert Saltmarsh has been named chief financial officer of Nanogen, the San Diego-based firm announced last week. Saltmarsh joined Nanogen in September as vice president of corporate development. He previously served as vice president of finance and treasurer for Apple Computer and Silicon Graphics. Saltmarsh holds a BA in economics and an MBA in finance from the University of Michigan.

Trevor Nicholls has been named to the European business development team of Affymetrix, effective Jan. 1. He previously served as executive vice president of product marketing and development.

Tony Colangelo has become vice president of North American sales and Olle Landström vice president of engineering for Spotfire, the Somerville, Mass.-based company announced. The company has also added several new field representatives in all regions. Colangelo joins Spotfire from Bristol Technologies, where he led the field sales team. Landström, who will be based in Göteborg, Sweden, comes to Spotfire from IAR Systems in Sweden, where he served as chief technology officer.

Michael Treble has become CEO of the Ibis program of Isis Pharmaceuticals, the company said last week. Ibis plans to develop a biosensor to identify infectious organisms. Prior to joining Isis, he founded Tienta Sciences and SonoPlot. Before that, he was president and CEO of NimbleGen Systems. He was also executive vice president, COO, and director of Third Wave Technologies. Treble holds an MBA from the University of Buffalo and a BS from Canisius College, also in Buffalo.

EMBL has established a Bioinformatics Advisory Committee. Members of the committee include Søren Brunak (Chairman) of the Technical University of Denmark, John Sulston of the Wellcome Trust Sanger Institute, Anna Tramontano of the University of Rome “La Sapienza,” Martin Vingron of the Max Planck Institute for Molecular Genetics, and Gunnar von Heijne of Stockholm University.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.